Skip to main content
. Author manuscript; available in PMC: 2006 Oct 5.
Published in final edited form as: Eur J Neurosci. 2005 Aug;22(4):785–792. doi: 10.1111/j.1460-9568.2005.04277.x

Fig. 2.

Fig. 2

(a) Diagram showing timescale of treatments, (b and c) Effects of the MR antagonist SPIR and GR antagonist MIFE on proliferation as demonstrated by (b) BrdU and (c) Ki-67 cell counts. Adrenalectomy significantly stimulated proliferation (§P < 0.001), and corticosterone replacement with a 30% corticosterone pellet restored proliferation to basal levels. SPIR significantly enhanced proliferation (P < 0.007), but there was no observed effect of MIFE. P < 0.043.